A 3-strain digestive capsule with 100 billion CFU for a US supplement brand — launched with clinical dossier support in 9 months.
A US DTC brand wanted to enter the digestive category with a science-led positioning. Tingbiotech developed a 3-strain formulation, generated the supporting clinical dossier and produced a launch batch of 2 million capsules in nine months from first call.
Key Features
100 billion CFU with DUO-CAP protection
Clinical dossier assembled for US label claims
Launch batch: 2 million capsules in 9 months
Amazon D2C launch with > 4.5-star average rating
Request a quote and our engineers will send you the full specification sheet, stability reports and free samples.